T65.842
Toxic effect of xylazine, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T65.842 refers to a toxic effect caused by xylazine, which occurs as a result of intentional self-harm. Xylazine is a medication used primarily as a sedative in veterinary medicine, but it can be misused by humans, leading to poisoning or overdose. This condition highlights the importance of recognizing the risks associated with xylazine misuse and the need for appropriate medical and psychological interventions.
Causes & Symptoms
Clinical Causes: Intentional overdose or misuse of xylazine as a form of self-harm Misjudged or accidental ingestion by individuals attempting to harm themselves Use of xylazine in illicit recreational drug mixtures to enhance sedative effects Lack of awareness about the potency and risks associated with xylazine
Key Symptoms: Severe drowsiness or sedation Respiratory depression or difficulty breathing Low blood pressure and weakness Unconsciousness or coma Bradycardia (slow heart rate) Possible skin reactions or injuries from the toxic effects Dizziness, confusion, or disorientation
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves medical evaluation including a detailed patient history, physical examination, and specific laboratory tests. Blood or urine tests can detect the presence of xylazine or related substances. Healthcare professionals may also assess for signs of organ dysfunction, respiratory failure, or neurological impairment. Imaging studies are generally not necessary unless complications arise.
Treatment Protocols: Treatment primarily focuses on managing symptoms and preventing complications. This may include:
Clinical Advice & FAQs
Billing Guidance
Is T65.842 a billable ICD-10 code?
Yes, T65.842 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T65.842?
Clinical documentation must specify the nature of Toxic effect of xylazine, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference